TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: KEGG enrichment analysis revealed the top ten enriched pathways were the human cytomegalovirus infection, toll-like receptor signaling, pertussis, allograft rejection, Th17 cell differentiation, p53 signaling, chronic myeloid leukemia, glioma, graft vs host disease, and Ras signaling (Table 3).